HIGHLIGHTS
- who: Emma Gerber from the (UNIVERSITY) have published the article: Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin, in the Journal: (JOURNAL)
- what: The authors investigated whether sEV-pGSN prior to treatment presents as a predictive biomarker of chemoresistance and compared with total pGSN and CA125. While this work provides an interesting proof of concept for evaluating pGSN as a biomarker for predicting EOC patients` response to chemotherapy, there is an important limitation that will need to be addressed in future work.
- future: Future work in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.